Universal Admission Screening for SARS-CoV-2 Infections among Hospitalized Patients, Switzerland, 2020

Emerg Infect Dis. 2021 Feb;27(2):404-410. doi: 10.3201/eid2702.202318. Epub 2021 Jan 4.

Abstract

Switzerland began a national lockdown on March 16, 2020, in response to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We assessed the prevalence of SARS-CoV-2 infection among patients admitted to 4 hospitals in the canton of Zurich, Switzerland, in April 2020. These 4 acute care hospitals screened 2,807 patients, including 2,278 (81.2%) who did not have symptoms of coronavirus disease (COVID-19). Overall, 529 (18.8%) persons had >1 symptom of COVID-19, of whom 60 (11.3%) tested positive for SARS-CoV-2. Eight asymptomatic persons (0.4%) also tested positive for SARS-CoV-2. Our findings indicate that screening on the basis of COVID-19 symptoms, regardless of clinical suspicion, can identify most SARS-CoV-2-positive persons in a low-prevalence setting.

Keywords: 2019 novel coronavirus disease; COVID-19; PCR; SARS-CoV-2; Switzerland; asymptomatic transmission; coronavirus; coronavirus disease; diagnosis; emerging infections; epidemiology; respiratory infections; screening; severe acute respiratory syndrome coronavirus 2; testing; viruses; zoonoses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • COVID-19 / diagnosis*
  • COVID-19 / epidemiology
  • COVID-19 / prevention & control
  • COVID-19 Testing / methods
  • COVID-19 Testing / statistics & numerical data*
  • Diagnostic Tests, Routine / methods
  • Diagnostic Tests, Routine / statistics & numerical data*
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Patient Admission / statistics & numerical data*
  • Prevalence
  • SARS-CoV-2
  • Switzerland / epidemiology
  • Universal Precautions / methods
  • Universal Precautions / statistics & numerical data*